Literature DB >> 33863789

Kdm6b Regulates the Generation of Effector CD8+ T Cells by Inducing Chromatin Accessibility in Effector-Associated Genes.

Tianhao Xu1,2, Alexander Schutte1, Leandro Jimenez3, Andre N A Gonçalves3, Ashleigh Keller1, Matthew E Pipkin4, Helder I Nakaya3, Renata M Pereira5, Gustavo J Martinez6,2.   

Abstract

The transcriptional and epigenetic regulation of CD8+ T cell differentiation is critical for balancing pathogen eradication and long-term immunity by effector and memory CTLs, respectively. In this study, we demonstrate that the lysine demethylase 6b (Kdm6b) is essential for the proper generation and function of effector CD8+ T cells during acute infection and tumor eradication. We found that cells lacking Kdm6b (by either T cell-specific knockout mice or knockdown using short hairpin RNA strategies) show an enhanced generation of memory precursor and early effector cells upon acute viral infection in a cell-intrinsic manner. We also demonstrate that Kdm6b is indispensable for proper effector functions and tumor protection, and that memory CD8+ T cells lacking Kdm6b displayed a defective recall response. Mechanistically, we identified that Kdm6b, through induction of chromatin accessibility in key effector-associated gene loci, allows for the proper generation of effector CTLs. Our results pinpoint the essential function of Kdm6b in allowing chromatin accessibility in effector-associated genes, and identify Kdm6b as a potential target for therapeutics in diseases with dysregulated effector responses.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Year:  2021        PMID: 33863789     DOI: 10.4049/jimmunol.2001459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  The histone demethylase Kdm6b regulates the maturation and cytotoxicity of TCRαβ+CD8αα+ intestinal intraepithelial lymphocytes.

Authors:  Haohao Zhang; Yiming Hu; Dandan Liu; Zhi Liu; Ningxia Xie; Sanhong Liu; Jie Zhang; Yuhang Jiang; Cuifeng Li; Qi Wang; Xi Chen; Deji Ye; Donglin Sun; Yujia Zhai; Xinhui Yan; Yongzhong Liu; Charlie Degui Chen; Xingxu Huang; Y Eugene Chin; Yufang Shi; Baojin Wu; Xiaoren Zhang
Journal:  Cell Death Differ       Date:  2022-01-09       Impact factor: 12.067

2.  NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma.

Authors:  Yu-Mei Ning; Kun Lin; Xiao-Ping Liu; Yang Ding; Xiang Jiang; Zhang Zhang; Yu-Ting Xuan; Li Dong; Lan Liu; Fan Wang; Qiu Zhao; Hai-Zhou Wang; Jun Fang
Journal:  BMC Gastroenterol       Date:  2022-08-20       Impact factor: 2.847

Review 3.  Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.

Authors:  Jeries Abu-Hanna; Jigisha A Patel; Evangelos Anastasakis; Richard Cohen; Lucie H Clapp; Marilena Loizidou; Mohammad M R Eddama
Journal:  Clin Epigenetics       Date:  2022-08-01       Impact factor: 7.259

Review 4.  A Screening of Epigenetic Therapeutic Targets for Non-Small Cell Lung Cancer Reveals PADI4 and KDM6B as Promising Candidates.

Authors:  Jéssika Cristina Chagas Lesbon; Taismara Kustro Garnica; Pedro Luiz Porfírio Xavier; Arina Lázaro Rochetti; Rui Manuel Reis; Susanne Müller; Heidge Fukumasu
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.